Vector(s) containing an inducible gene encoding a cell cycle regulator useful for treating neurodegenerative disorders

The present invention provides a vector containing a gene useful for treating neurodegenerative disorders, especially Alzheimer’s disease. These vectors can be used in therapeutic applications to prevent neurodegenerative disorders or to slow down their progression with therapeutic efficacy. The invention comprises a gene therapeutic approach based on neuron-specific targeting of cell cycle activation and progression.

patent pending: EP2218784A1 and US20120004277A1

Further Information: PDF

GWT-TUD GmbH; FB Sächsische PatentVerwertungsAgentur (SPVA)
Phone: +49 351 25933 120

Contact
Beate-Victoria Ermisch

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Innovative 3D printed scaffolds offer new hope for bone healing

Researchers at the Institute for Bioengineering of Catalonia have developed novel 3D printed PLA-CaP scaffolds that promote blood vessel formation, ensuring better healing and regeneration of bone tissue. Bone is…

The surprising role of gut infection in Alzheimer’s disease

ASU- and Banner Alzheimer’s Institute-led study implicates link between a common virus and the disease, which travels from the gut to the brain and may be a target for antiviral…

Molecular gardening: New enzymes discovered for protein modification pruning

How deubiquitinases USP53 and USP54 cleave long polyubiquitin chains and how the former is linked to liver disease in children. Deubiquitinases (DUBs) are enzymes used by cells to trim protein…